2007
1. Arai A, Yan W, Wakabayashi S, Hayashi S, Inazawa J, Miura O: Successful imatinib treatment of cardiac involvement of FIP1L1-PDGFRA-Positive chronic eosinophilic leukemia followed by severe hepatotoxicity. Int J Hematol.86:233-7, 2007
2. Katoh H, Ojima H, Kokubu A, Saito S, Kondo T, Kosuge T, Hosoda F, Imoto I, Inazawa J, Hirohashi S, Shibata T: Genetically distinct and clinically relevant classification of hepatocellular carcinoma: putative therapeutic targets.Gastroenterology.133:1475-86, 2007
3. Okamoto N, Kubota T, Nakamura Y, Murakami R, Nishikubo T, Tanaka I, Takahashi Y, Hayashi S, Imoto I, Inazawa J, Hosokai N, Kohsaka S, Uchino S:22q13 microduplication in two patients with common clinical manifestations: A recognizable syndrome? Am J Med Genet A.143:2804-9, 2007
4. Udaka T, Imoto I, Aizu Y, Torii C, Izumi K, Kosaki R, Takahashi T, Hayashi S, Inazawa J, Kosaki K: Multiplex PCR/Liquid chromatography assay for screening of subtelomeric rearrangements.Genet Test.11:241-8, 2007
5. Yamamoto S, Tsuda H, Honda K, Kita T, Takano M, Tamai S, Inazawa J, Yamada T, Matsubara O: Actinin-4 expression in ovarian cancer: a novel prognostic indicator independent of clinical stage and histological type. Mod Pathol. 20:1278-85, 2007
6. Mitsui F, Dobashi Y, Imoto I, Inazawa J, Kono K, Fujii H, Ooi A: Non-incidental coamplification of Myc and ERBB2,and Myc and EGFR,in gastric adenocarcinomas. Mod Pathol. 20,622-631, 2007
7. Morita D, Tsuda H, Ichikura T, Kimura M, Aida S, Kosuda S, Inazawa J, Mochizuki H, Matsubara O: Analysis of Sentinel Node Involvement in Gastric Cancer.Clin Gastroenterol Hepatol.5;1046-1052, 2007
8. Amino T, Ishikawa K, Toru S, Ishiguro T, Sato N, Tsunemi T, Murata M, Kobayashi K, Inazawa J, Toda T, Mizusawa H: Redefining the disease locus of 16q22.1-linked autosomal dominant cerebellar ataxia. J Hum Genet.52:643-9, 2007
9. Yamamoto S, Tsuda H, Kita T, Maekawa K, Fujii K, Kudoh K, Furuya K, Tamai S, Inazawa J, Matsubara O: Clinicopathological significance of WT1 expression in ovarian cancer: a possible accelerator of tumor progression in serous adenocarcinoma. Virchows Arch.451：27-35, 2007
10. Kawanishi H, Takahashi T, Ito M, Matsui Y, Watanabe J, Ito N, Kamoto T, Kadowaki T, Tsujimoto G, Imoto I, Inazawa J, Nishiyama H, Ogawa O: Genetic analysis of multifocal superficial urothelial cancers by array-based comparative genomic hybridisation. Br J Cancer. 97:260-6, 2007
11. Chiyonobu T, Hayashi S, Kobayashi K, Morimoto M, Miyanomae Y, Nishimura A, Nishimoto A, Ito C, Imoto I, Sugimoto T, Jia Z, Inazawa J, Toda T: Partial tandem duplication of GRIA3 in a male with mental retardation. Am J Med Genet A.. 143:1448-5, 2007
12. Kikuchi R, Tsuda H, Kanai Y, Kasamatsu T, Sengoku K, Hirohashi S, Inazawa J, Imoto I: Promoter hypermethylation contributes to frequent inactivation of a putative conditional tumor suppressor gene connective tissue growth factor in ovarian cancer . Cancer Res.67:7095-7105, 2007
13. Suzuki E, Imoto I, Pimkhaokham A, Nakagawa T, Kamata N, Kozaki K,Amagasa T, Inazawa J: PRTFDC1, a possible tumor-suppressor gene, is frequently silenced in oral squamous-cell carcinomas by aberrant promoter hypermethylation. Oncogene. 26:7921-32, 2007
14. Sugino Y, Misawa A, Inoue J, KitagawaM, Hosoi H, Sugimoto T, Imoto I, Inazawa J: Epigenetic silencing of prostaglandin E receptor 2 (PTGER2) is associated with progression of neuroblastomas. Oncogene. 26:7401-13, 2007
15. Tanaka K, Imoto I, Inoue J, Kozaki K, Tsuda H, Shimada Y, Aiko S, Yoshizumi Y, Iwai T, Kawano T, Inazawa J: Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma. Oncogene.26: 6456-68, 2007
16. Shinoda Y, Kozaki K, Imoto I, Obara W, Tsuda H, Mizutani Y, Shuin T, Fujioka T, Miki T, Inazawa J: Association of KLK5-overexpression with invasiveness of urinary bladder carcinoma cells. Cancer Sci.98:1078-1086, 2007
17. Kawasaki T, Yokoi S, Tsuda H, Izumi H, Kozaki k, Aida S, Ozeki Y, Yoshizawa Y, Imoto I, Inazawa J: BCL2L2 is a probable target for novel 14q11.2 amplification detected in a non-small cell lung cancer cell line. Cancer Sci.98:1070-7, 2007
18. Hayashi S, Ono M, Makita Y, Imoto I, Mizutani S, Inazawa J: Fortuitous detection of a submicroscopic deletion at 1q25 in a girl with cornelia-de lange syndrome carrying t(5;13)(p13.1;q12.1) by array-based comparative genomic hybridization. Am J Med Genet A.143:1191-7, 2007
19. Hayashi S, Honda S, Minaguchi M, Makita Y, Okamoto N, Kosaki R, Okuyama T, Imoto I, Mizutani S, Inazawa J: Construction of a high-density and high-resolution human chromosome X array for comparative genomic hybridization analysis. J Hum Genet.52:397-405, 2007
20. Tokutomi T, Hayashi S, Imai K, Chida A, Ishiwata T, Asano Y, Inazawa J, Nonoyama S: Dup(8p)/del(8q) recombinant chromosome in a girl with hepatic focal nodular hyperplasia. Am J Med Genet A.143:1334-7, 2007
21. Honda S, Hayashi S, Kato M, Niida Y, Hayasaka K, Okuyama T, Imoto I, Mizutani S, Inazawa J: Clinical and molecular cytogenetic characterization od two patients with non-mutational aberrations of the FMR2 gene. Am J Med Genet. 143:687-93, 2007
22. Tanaka E, Hashimoto Y, Ito T, Kondo K, Higashiyama M, Tsunoda S, Ortiz C, Sakai Y, Inazawa J, Shimada Y: The suppression of aurora-A/STK15/BTAK expression enhances chemosensitivity to docetaxel in human esophageal squamous cell carcinoma. Clin Cancer Res.13:1331-40, 2007
23. Loukopoulos P, Shibata T, Katoh H, Kokubu A, Sakamoto M, Yamazaki K, Kosuge T, Kanai Y, Hosoda F, Imoto I, Ohki M, Inazawa J, Hirohashi S: Genome-wide array-based comparative genomic hybridization analysis of pancreatic adenocarcinoma: identification of genetic indicators that predict patient outcome. Cancer Sci.98:392-400, 2007
24. Maekawa T, Shinagawa T, Sano Y, Sakuma T, Nomura S, Nagasaki K, Miki Y, Saito-Ohara F, Inazawa J, Kohno T, Yokota J, Ishii S: Reduced levels of ATF-2 predispose mice to mammary tumors. Mol Cell Biol.27:1730-44, 2007
25. Saigusa K, Imoto I, Tanikawa C, Aoyagi M, Ohno K, Nakamura Y, Inazawa J: RGC32, a novel p53-inducible gene, is located on centrosomes during mitosis and results in G2/M arrest. Oncogene.26:1110-21, 2007
2. Katoh H, Ojima H, Kokubu A, Saito S, Kondo T, Kosuge T, Hosoda F, Imoto I, Inazawa J, Hirohashi S, Shibata T: Genetically distinct and clinically relevant classification of hepatocellular carcinoma: putative therapeutic targets.Gastroenterology.133:1475-86, 2007
3. Okamoto N, Kubota T, Nakamura Y, Murakami R, Nishikubo T, Tanaka I, Takahashi Y, Hayashi S, Imoto I, Inazawa J, Hosokai N, Kohsaka S, Uchino S:22q13 microduplication in two patients with common clinical manifestations: A recognizable syndrome? Am J Med Genet A.143:2804-9, 2007
4. Udaka T, Imoto I, Aizu Y, Torii C, Izumi K, Kosaki R, Takahashi T, Hayashi S, Inazawa J, Kosaki K: Multiplex PCR/Liquid chromatography assay for screening of subtelomeric rearrangements.Genet Test.11:241-8, 2007
5. Yamamoto S, Tsuda H, Honda K, Kita T, Takano M, Tamai S, Inazawa J, Yamada T, Matsubara O: Actinin-4 expression in ovarian cancer: a novel prognostic indicator independent of clinical stage and histological type. Mod Pathol. 20:1278-85, 2007
6. Mitsui F, Dobashi Y, Imoto I, Inazawa J, Kono K, Fujii H, Ooi A: Non-incidental coamplification of Myc and ERBB2,and Myc and EGFR,in gastric adenocarcinomas. Mod Pathol. 20,622-631, 2007
7. Morita D, Tsuda H, Ichikura T, Kimura M, Aida S, Kosuda S, Inazawa J, Mochizuki H, Matsubara O: Analysis of Sentinel Node Involvement in Gastric Cancer.Clin Gastroenterol Hepatol.5;1046-1052, 2007
8. Amino T, Ishikawa K, Toru S, Ishiguro T, Sato N, Tsunemi T, Murata M, Kobayashi K, Inazawa J, Toda T, Mizusawa H: Redefining the disease locus of 16q22.1-linked autosomal dominant cerebellar ataxia. J Hum Genet.52:643-9, 2007
9. Yamamoto S, Tsuda H, Kita T, Maekawa K, Fujii K, Kudoh K, Furuya K, Tamai S, Inazawa J, Matsubara O: Clinicopathological significance of WT1 expression in ovarian cancer: a possible accelerator of tumor progression in serous adenocarcinoma. Virchows Arch.451：27-35, 2007
10. Kawanishi H, Takahashi T, Ito M, Matsui Y, Watanabe J, Ito N, Kamoto T, Kadowaki T, Tsujimoto G, Imoto I, Inazawa J, Nishiyama H, Ogawa O: Genetic analysis of multifocal superficial urothelial cancers by array-based comparative genomic hybridisation. Br J Cancer. 97:260-6, 2007
11. Chiyonobu T, Hayashi S, Kobayashi K, Morimoto M, Miyanomae Y, Nishimura A, Nishimoto A, Ito C, Imoto I, Sugimoto T, Jia Z, Inazawa J, Toda T: Partial tandem duplication of GRIA3 in a male with mental retardation. Am J Med Genet A.. 143:1448-5, 2007
12. Kikuchi R, Tsuda H, Kanai Y, Kasamatsu T, Sengoku K, Hirohashi S, Inazawa J, Imoto I: Promoter hypermethylation contributes to frequent inactivation of a putative conditional tumor suppressor gene connective tissue growth factor in ovarian cancer . Cancer Res.67:7095-7105, 2007
13. Suzuki E, Imoto I, Pimkhaokham A, Nakagawa T, Kamata N, Kozaki K,Amagasa T, Inazawa J: PRTFDC1, a possible tumor-suppressor gene, is frequently silenced in oral squamous-cell carcinomas by aberrant promoter hypermethylation. Oncogene. 26:7921-32, 2007
14. Sugino Y, Misawa A, Inoue J, KitagawaM, Hosoi H, Sugimoto T, Imoto I, Inazawa J: Epigenetic silencing of prostaglandin E receptor 2 (PTGER2) is associated with progression of neuroblastomas. Oncogene. 26:7401-13, 2007
15. Tanaka K, Imoto I, Inoue J, Kozaki K, Tsuda H, Shimada Y, Aiko S, Yoshizumi Y, Iwai T, Kawano T, Inazawa J: Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma. Oncogene.26: 6456-68, 2007
16. Shinoda Y, Kozaki K, Imoto I, Obara W, Tsuda H, Mizutani Y, Shuin T, Fujioka T, Miki T, Inazawa J: Association of KLK5-overexpression with invasiveness of urinary bladder carcinoma cells. Cancer Sci.98:1078-1086, 2007
17. Kawasaki T, Yokoi S, Tsuda H, Izumi H, Kozaki k, Aida S, Ozeki Y, Yoshizawa Y, Imoto I, Inazawa J: BCL2L2 is a probable target for novel 14q11.2 amplification detected in a non-small cell lung cancer cell line. Cancer Sci.98:1070-7, 2007
18. Hayashi S, Ono M, Makita Y, Imoto I, Mizutani S, Inazawa J: Fortuitous detection of a submicroscopic deletion at 1q25 in a girl with cornelia-de lange syndrome carrying t(5;13)(p13.1;q12.1) by array-based comparative genomic hybridization. Am J Med Genet A.143:1191-7, 2007
19. Hayashi S, Honda S, Minaguchi M, Makita Y, Okamoto N, Kosaki R, Okuyama T, Imoto I, Mizutani S, Inazawa J: Construction of a high-density and high-resolution human chromosome X array for comparative genomic hybridization analysis. J Hum Genet.52:397-405, 2007
20. Tokutomi T, Hayashi S, Imai K, Chida A, Ishiwata T, Asano Y, Inazawa J, Nonoyama S: Dup(8p)/del(8q) recombinant chromosome in a girl with hepatic focal nodular hyperplasia. Am J Med Genet A.143:1334-7, 2007
21. Honda S, Hayashi S, Kato M, Niida Y, Hayasaka K, Okuyama T, Imoto I, Mizutani S, Inazawa J: Clinical and molecular cytogenetic characterization od two patients with non-mutational aberrations of the FMR2 gene. Am J Med Genet. 143:687-93, 2007
22. Tanaka E, Hashimoto Y, Ito T, Kondo K, Higashiyama M, Tsunoda S, Ortiz C, Sakai Y, Inazawa J, Shimada Y: The suppression of aurora-A/STK15/BTAK expression enhances chemosensitivity to docetaxel in human esophageal squamous cell carcinoma. Clin Cancer Res.13:1331-40, 2007
23. Loukopoulos P, Shibata T, Katoh H, Kokubu A, Sakamoto M, Yamazaki K, Kosuge T, Kanai Y, Hosoda F, Imoto I, Ohki M, Inazawa J, Hirohashi S: Genome-wide array-based comparative genomic hybridization analysis of pancreatic adenocarcinoma: identification of genetic indicators that predict patient outcome. Cancer Sci.98:392-400, 2007
24. Maekawa T, Shinagawa T, Sano Y, Sakuma T, Nomura S, Nagasaki K, Miki Y, Saito-Ohara F, Inazawa J, Kohno T, Yokota J, Ishii S: Reduced levels of ATF-2 predispose mice to mammary tumors. Mol Cell Biol.27:1730-44, 2007
25. Saigusa K, Imoto I, Tanikawa C, Aoyagi M, Ohno K, Nakamura Y, Inazawa J: RGC32, a novel p53-inducible gene, is located on centrosomes during mitosis and results in G2/M arrest. Oncogene.26:1110-21, 2007